![Anthony Polverino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 19 298 $ per 2026-05-31
Dr. Anthony J.
Polverino is an Independent Director at Brainstorm Cell Therapeutics, Inc. He is on the Board of Directors at Brainstorm Cell Therapeutics, Inc. Dr. Polverino was previously employed as a Chief Scientific Officer & EVP-Early Development by Zymeworks BC, Inc., a Chief Scientific Officer by Kite Pharma, Inc., an Executive Director-Therapeutic Innovation Unit by Amgen, Inc., and a Chief Scientific Officer & EVP-Early Development by Zymeworks, Inc. He received his undergraduate degree from the University of Adelaide and a doctorate degree from Flinders University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-26 | 25 730 ( 0,23 % ) | 19 298 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Direktör/Styrelseledamot | 2018-02-05 |
| Företag | Position | Slut |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-19 |
| KITE PHARMA INC | Teknisk/Vetenskaplig/F&U Direktör | 2018-01-01 |
| ZYMEWORKS INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
| AMGEN INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flinders University
 Flinders University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
